All stock lists
Axogen, Inc. (NASDAQ:AXGN)
US · Delayed Price · Currency is USD
Also listed: 0HKD.LHealthcare · Medical - Devices
38.17+0.12 (+0.30%)
Insider Score
––Not scored
AXGN Insider Score
Insiders filed in the last 90 days, but none of those trades qualified for scoring — round-trip buys and filings whose price is far off the market are excluded.
AXGN Income Statement
| Fiscal Period | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 | Mar 31, 2025 |
| Revenue | 69.73 M | 61.46 M | 59.90 M | 60.08 M | 56.66 M | 48.56 M |
| Revenue Growth (YoY) | 23.06 % | 26.56 % | 21.25 % | 23.51 % | 18.26 % | 17.36 % |
| Cost of Revenue | 19.06 M | 15.27 M | 15.49 M | 14.09 M | 14.64 M | 13.63 M |
| Gross Profit | 50.67 M | 46.19 M | 44.41 M | 45.99 M | 42.02 M | 34.93 M |
| SG&A Expense | 44.24 M | 41.50 M | 41.80 M | 36.52 M | 33.49 M | 30.50 M |
| R&D Expense | 8.59 M | 7.52 M | 12.38 M | 7.57 M | 6.85 M | 6.09 M |
| Operating Expenses | 52.83 M | 49.02 M | 54.18 M | 44.08 M | 40.35 M | 36.59 M |
| Operating Income | -2.16 M | -2.83 M | -9.77 M | 1.91 M | 1.67 M | -1.66 M |
| Pretax Income | -1.52 M | -19.58 M | -13.16 M | 708.00 K | 579.00 K | -3.83 M |
| Tax Provision | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income | -1.52 M | -19.58 M | -13.16 M | 708.00 K | 579.00 K | -3.83 M |
| EPS (Basic) | -0.03 | -0.38 | -0.28 | 0.02 | 0.01 | -0.08 |
| EPS (Diluted) | -0.03 | -0.38 | -0.28 | 0.01 | 0.01 | -0.08 |
| Shares Outstanding | 53.34 M | 51.59 M | 46.93 M | 45.91 M | 45.61 M | 45.20 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.
